» Articles » PMID: 35218034

COVID-19 Pathophysiology and Ultrasound Imaging: A Multiorgan Review

Abstract

COVID-19 is a dynamic disease and may affect different tissues and organs as it progresses. Therefore, the impact generated by the disease in all its stages and organs requires a functional and versatile imaging technique able to detect particularities or artifacts dynamically. Ultrasonography fulfills all these requirements and exhibit several advantages relative to other imaging modalities, including portability, lower cost and biosafety. Throughout the COVID-19 pandemic, ultrasonography displayed a crucial role in the triage, monitoring, indicating organ damages and enabling individualized therapeutical decisions in COVID-19 patients. This review is dedicated to highlight the main pathological effects correlated with ultrasound changes caused by COVID-19 in the lungs, heart and liver.

Citing Articles

Tiny Lungs, Big Differences: Navigating the Varied COVID-19 Landscape in Neonates vs. Infants via Biomarkers and Lung Ultrasound.

Stoicescu E, Iacob R, Iacob E, Ghenciu L, Oancea C, Manolescu D Biomedicines. 2024; 12(2).

PMID: 38398027 PMC: 10886952. DOI: 10.3390/biomedicines12020425.


Critical Advances for Democratizing Ultrasound Diagnostics in Human and Veterinary Medicine.

El Kaffas A, Vo-Phamhi J, Griffin J, Hoyt K Annu Rev Biomed Eng. 2024; 26(1):49-65.

PMID: 38166185 PMC: 11238906. DOI: 10.1146/annurev-bioeng-110222-095229.


Oxygen therapy alternatives in COVID-19: From classical to nanomedicine.

Pereira L, Dallagnol C, Moulepes T, Hirota C, Kutsmi P, Dos Santos L Heliyon. 2023; 9(4):e15500.

PMID: 37089325 PMC: 10106793. DOI: 10.1016/j.heliyon.2023.e15500.


Effects of Adding an Online Exercise Program on Physical Function in Individuals Hospitalized by COVID-19: A Randomized Controlled Trial.

Llurda-Almuzara L, Rodriguez-Sanz J, Lopez-de-Celis C, Aiguade-Aiguade R, Aran-Jove R, Labata-Lezaun N Int J Environ Res Public Health. 2022; 19(24).

PMID: 36554510 PMC: 9778879. DOI: 10.3390/ijerph192416619.


COVID-19 pathophysiology and ultrasound imaging: A multiorgan review.

Ito G, Rodrigues V, Hummelgen J, Meschino G, Abou-Rejaile G, Brenny I J Clin Ultrasound. 2022; 50(3):326-338.

PMID: 35218034 PMC: 9088355. DOI: 10.1002/jcu.23160.

References
1.
Nardo A, Schneeweiss-Gleixner M, Bakail M, Dixon E, Lax S, Trauner M . Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2020; 41(1):20-32. PMC: 7753756. DOI: 10.1111/liv.14730. View

2.
Ashraf U, Abokor A, Edwards J, Waigi E, Royfman R, Hasan S . SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol Genomics. 2020; 53(2):51-60. PMC: 7900915. DOI: 10.1152/physiolgenomics.00087.2020. View

3.
Chan-Yeung M, Xu R . SARS: epidemiology. Respirology. 2004; 8 Suppl:S9-14. PMC: 7169193. DOI: 10.1046/j.1440-1843.2003.00518.x. View

4.
Wasim D, Alme B, Jordal S, Eagan T, Tadic M, Mancia G . Characteristics of 24-hour ambulatory blood pressure monitoring in a COVID-19 survivor. Future Cardiol. 2021; 17(8):1321-1326. PMC: 8056747. DOI: 10.2217/fca-2020-0235. View

5.
Zhang C, Shi L, Wang F . Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020; 5(5):428-430. PMC: 7129165. DOI: 10.1016/S2468-1253(20)30057-1. View